Abbott Labs (ABT) stock price target cut to $120 by Benchmark
Published on 4/17/2026
AI Summary
Summarized by AI from the source belowBenchmark has reduced its price target for Abbott Labs (ABT) stock to $120. This change reflects a re-evaluation of the company's valuation metrics. Such a downgrade can influence market perceptions and potentially impact stock performance. It is essential to monitor how this adjustment affects trading volume and investor sentiment moving forward.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
